Several studies of paired blood-tumor samples highlight the need for more nuanced diagnostic approach than peripheral blood testing as corresponding tumor samples may not contain any TP53 alterations and thus are not part of Li-Fraumeni syndrome spectrum [53, 54]. Here, TP53 is linked to neoplasm.